Structural Effects of Some Relevant Missense Mutations on the MECP2‐DNA Binding: A MD Study Analyzed by Rescore+, a Versatile Rescoring Tool of the VEGA ZZ Program

DNA methylation plays key roles in mammalian cells and is modulated by a set of proteins which recognize symmetrically methylated nucleotides. Among them, the protein MECP2 shows multifunctional roles repressing and/or activating genes by binding to both methylated and unmethylated regions of the genome. The interest for this protein markedly increased from the observation that its mutations are the primary cause of Rett syndrome, a neurodevelopmental disorder which causes mental retardation in young females. Thus, the present study is aimed to investigate the effects of some of these known pathogenic missense mutations (i.e. R106Q, R106W, R111G, R133C and R133H) on the MECP2 folding and DNA binding by molecular dynamics simulations. The effects of the simulated mutations are also parameterized by using a here proposed new tool, named Rescore+, implemented in the VEGA ZZ suite of programs, which calculates a set of scoring functions on all frames of a trajectory or on all complexes contained in a database thus allowing an easy rescoring of results coming from MD or docking simulations. The obtained results revealed that the reported loss of the MECP2 function induced by the simulated mutations can be ascribed to both stabilizing and destabilizing effect on DNA binding. The study confirms that MD simulations are particularly useful to rationalize and predict the mutation effects offering insightful information for diagnostics and drug design.

[1]  P N Barlow,et al.  The solution structure of the domain from MeCP2 that binds to methylated DNA. , 1999, Journal of molecular biology.

[2]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[4]  Laxmikant V. Kale,et al.  NAMD2: Greater Scalability for Parallel Molecular Dynamics , 1999 .

[5]  Alessandro Pedretti,et al.  In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations. , 2010, Bioorganic & medicinal chemistry.

[6]  Jim Selfridge,et al.  The role of MeCP2 in the brain. , 2009, Annual review of cell and developmental biology.

[7]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[8]  Alessandro Pedretti,et al.  VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. , 2002, Journal of molecular graphics & modelling.

[9]  P. Georgel,et al.  MeCP2: structure and function. , 2011, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[10]  J. Thornton,et al.  Stereochemical quality of protein structure coordinates , 1992, Proteins.

[11]  Valerie H Adams,et al.  Intrinsic Disorder and Autonomous Domain Function in the Multifunctional Nuclear Protein, MeCP2* , 2007, Journal of Biological Chemistry.

[12]  Thomas Stützle,et al.  Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS , 2009, J. Chem. Inf. Model..

[13]  D. Patel,et al.  DNA methylation pathways and their crosstalk with histone methylation , 2015, Nature Reviews Molecular Cell Biology.

[14]  C. Clementi,et al.  Discovering mountain passes via torchlight: methods for the definition of reaction coordinates and pathways in complex macromolecular reactions. , 2013, Annual review of physical chemistry.

[15]  A. Bird,et al.  MeCP2 binding to DNA depends upon hydration at methyl-CpG. , 2008, Molecular cell.

[16]  D. Osguthorpe,et al.  Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system , 1988, Proteins.

[17]  Lin Wang,et al.  Analyzing Effects of Naturally Occurring Missense Mutations , 2012, Comput. Math. Methods Medicine.

[18]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[19]  H. Zoghbi,et al.  MECP2 disorders: from the clinic to mice and back. , 2015, The Journal of clinical investigation.

[20]  A. Bird,et al.  Rett syndrome: a complex disorder with simple roots , 2015, Nature Reviews Genetics.

[21]  M. Nakao,et al.  Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain , 2003, Journal of medical genetics.

[22]  I. Weber,et al.  Molecular mechanics calculations on rous sarcoma virus protease with peptide substrates , 1997, Protein science : a publication of the Protein Society.

[23]  E. Ballestar,et al.  Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. , 2000, Biochemistry.

[24]  Luhua Lai,et al.  Further development and validation of empirical scoring functions for structure-based binding affinity prediction , 2002, J. Comput. Aided Mol. Des..

[25]  K. Schulten,et al.  Recognition of methylated DNA through methyl-CpG binding domain proteins , 2011, Nucleic acids research.